We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation
AGTC

Delisted

AGTC was delisted on the 30th of November, 2022.

Back to rankings

62 hedge funds and large institutions have $30M invested in Applied Genetic Technologies Corporation in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 67 → 62 (-5)

11% less capital invested

Capital invested by funds: $33.6M → $30M (-$3.56M)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

58% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 24

Holders
62
Holders Change
-5
Holders Change %
-7.46%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
10
Reduced
24
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$816K
2
MERSOM
Municipal Employees' Retirement System of Michigan
Michigan
+$471K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$429K
4
Renaissance Technologies
Renaissance Technologies
New York
+$412K
5
SIM
Spark Investment Management
New York
+$224K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$724K
2
Millennium Management
Millennium Management
New York
-$394K
3
GCP
GSA Capital Partners
United Kingdom
-$332K
4
AL
AJO LP
Pennsylvania
-$241K
5
American Century Companies
American Century Companies
Missouri
-$222K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$219K +$52.9K +14,011 +30%
Connor, Clark & Lunn Investment Management (CC&L)
27
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$218K -$35.9K -9,500 -14%
Morgan Stanley
28
Morgan Stanley
New York
$209K -$15.5K -4,104 -7%
Deutsche Bank
29
Deutsche Bank
Germany
$194K -$153K -40,641 -43%
Bank of America
30
Bank of America
North Carolina
$173K – – –
MCM
31
Matarin Capital Management
New York
$130K – – –
FDCDDQ
32
Federation des caisses Desjardins du Quebec
Quebec, Canada
$94.4K – – –
Two Sigma Advisers
33
Two Sigma Advisers
New York
$76K +$80.1K +21,207 New
Northern Trust
34
Northern Trust
Illinois
$75K -$2.18K -577 -3%
AA
35
Ancora Advisors
Ohio
$72K – – –
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$70K -$146K -38,642 -67%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$65K – – –
Squarepoint
38
Squarepoint
New York
$61K -$109K -28,800 -63%
Citadel Advisors
39
Citadel Advisors
Florida
$60K -$93.4K -24,737 -60%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$58K +$60.4K +15,990 New
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$53K – – –
Jacobs Levy Equity Management
42
Jacobs Levy Equity Management
New Jersey
$50K +$52.9K +14,000 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$49K -$11.5K -3,033 -18%
TSS
44
Two Sigma Securities
New York
$47K +$48.8K +12,927 New
UBS Group
45
UBS Group
Switzerland
$46K +$47.9K +12,680 New
Ameriprise
46
Ameriprise
Minnesota
$43K +$45.3K +12,000 New
Macquarie Group
47
Macquarie Group
Australia
$41K +$13.9K +3,677 +49%
Bank of New York Mellon
48
Bank of New York Mellon
New York
$40K -$145K -38,516 -78%
PP
49
PDT Partners
New York
$40K -$22.2K -5,881 -34%
FCMT
50
Founders Capital Management (Texas)
Texas
$14K – – –
1
2
3 4

AGTC Hedge Fund Activity: Q4 2017 in Review

62 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2017, worth a combined $30M — down 11% from $33.6M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AGTC and 10 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 10 added.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $816K. The largest seller was Fidelity Investments, cutting an estimated $724K.

  • 62 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2017, down from 67 in Q3 2017.
  • Funds reported $30M of Applied Genetic Technologies Corporation stock for Q4 2017, down 11% quarter-over-quarter.
  • 10 funds opened new Applied Genetic Technologies Corporation positions in Q4 2017 and 14 closed out, a net change of -4 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q4 2017 was 683 Capital Management, an estimated $816K added.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2017 was Fidelity Investments, an estimated $724K sold.

Based on aggregated 13F filings for Q4 2017.